A recent FiercePharma article discussed the recall of Pfizer’s menopause drug, Duavee. The company voluntarily recalled two batches of the drug, which is marketed as Duavive abroad, over concerns of faulty packaging that might have reduced efficacy. A flaw in the drug’s foil laminate pouch allows oxygen to pass through, lowering the dissolution rate of the active pharmaceutical ingredient, bazedoxifene acetate.
Quick Hits: Faulty Packaging Prompts Pfizer Recalls in UK
The drug’s packaging featured a flaw that lowered the dissolution rate of the API.
Jun 26, 2020
Recommended
Recommended
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
